
Kryporab D 30mg/20mg Capsule SR
Marketer
Kryptomed Formulations Pvt Ltd
Salt Composition
Domperidone (30mg) + Rabeprazole (20mg)
Overview Kryporab D 30mg/20mg Capsule SR
Gastroesophageal reflux disease (GERD, or acid reflux) is treated with the combination medication, Kryporab D 30mg/20mg Sustained-Release Capsules. This medication alleviates acidity symptoms like heartburn, stomach upset, and irritation by neutralizing stomach acid and facilitating gas expulsion for improved comfort. Kryporab D 30mg/20mg SR Capsules should be taken on an empty stomach, following your physician's prescribed dosage and duration. Dosage is individualized based on your response and condition; continued use as directed is crucial to prevent symptom recurrence and disease exacerbation. Inform your doctor of all other medications you're using, as interactions are possible. Common side effects, often transient, include diarrhea, abdominal pain, dry mouth, headache, gas, and fatigue. Report any concerning side effects immediately. Drowsiness and dizziness are potential side effects; avoid driving or mentally demanding tasks until the medication's impact is understood. Alcohol consumption should be avoided due to potential increased drowsiness. Lifestyle adjustments, such as consuming cool milk and avoiding hot beverages, spicy foods, and chocolate, can enhance treatment outcomes. Prior to commencing treatment, disclose any kidney or liver conditions, pregnancy, pregnancy plans, or breastfeeding to your doctor.
Uses of Kryporab D 30mg/20mg Capsule SR
Managing gastroesophageal reflux and peptic ulcers.
Major Benefits of Kryporab D 30mg/20mg Capsule SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire capsule without chewing, crushing, or breaking it. Kryporab D 30mg/20mg Sustained-Release Capsules should be taken on an empty stomach.
Common Side effects of Kryporab D 30mg/20mg Capsule SR:
- Pharyngitis
- Cough
- Headache
- Diarrhea
- Dizziness
- Inflammation of the nose
- Abdominal pain
- Vomiting
- Weakness
- Insomnia (difficulty in sleeping)
- Nausea
- Constipation
- Flatulence
- Nasal congestion (stuffy nose)
- Fundic gland polyps
- Back pain
How to use Kryporab D 30mg/20mg Capsule SR:
Consume Kryporab D 30mg/20mg SR capsules precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the capsule whole; avoid crushing, chewing, or breaking it. Administer the medication on an empty stomach.
How Kryporab D 30mg/20mg Capsule SR works:
Kryporab D 30mg/20mg sustained-release capsules contain Domperidone and Rabeprazole. Domperidone, a gastrointestinal motility stimulant, enhances upper digestive tract function, facilitating smoother food passage. Rabeprazole, a proton pump inhibitor (PPI), diminishes stomach acid production, providing relief from acid indigestion and heartburn symptoms.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Kryporab D 30mg/20mg SR capsules with alcohol. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
The use of Kryporab D 30mg/20mg sustained-release capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Kryporab D 30mg/20mg capsule is likely unsafe for breastfeeding mothers. Available evidence in humans indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Kryporab D 30mg/20mg sustained-release capsules might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should use Kryporab D 30mg/20mg sustained-release capsules cautiously. Dosage modification may be necessary; physician consultation is advised.
LiverCAUTION
Individuals with liver impairment should exercise caution when taking Kryporab D 30mg/20mg sustained-release capsules. Dosage modification may be necessary. Medical advice is recommended. Kryporab D 30mg/20mg sustained-release capsules are contraindicated in patients exhibiting moderate to severe hepatic dysfunction.
What if you forget to take Kryporab D 30mg/20mg Capsule SR :
Should you forget a dose of Kryporab D 30mg/20mg sustained-release capsules, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Kryporab D 30mg/20mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
